538964 — MERCURY LABORATORIES Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for MERCURY LABORATORIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	686	579	753	756	751
Cost of Revenue
Gross Profit	374	343	449	453	462
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	609	534	692	693	710
Operating Profit	76.7	45.4	60.9	62.1	41.4
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	79.1	50.3	74.9	69.2	46.6
Provision for Income Taxes
Net Income After Taxes	53.4	35.6	55.8	56.5	31.4
Net Income Before Extraordinary Items
Net Income	53.4	35.6	55.8	56.5	31.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	53.4	35.6	55.8	56.5	31.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	51.4	29.7	46.5	47.1	26.2
Dividends per Share